MoneyWorks4Me

Shilpa Medicare informs about outcome of board meeting

29 Oct 2021 Evaluate

Shilpa Medicare has informed that the Board of Directors of Shilpa Medicare at their meeting held today i.e., 29 October 2021 resolved the following: Approval of Unaudited Standalone and Consolidated Financial Results of the Company for the Second Quarter and Half Year ended 30 September 2021. The Copy of Financial Results and Limited Review Report is enclosed. The Board meeting commenced at 12:30 PM and concluded at 03: 00 PM.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..